CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - 0874 CFD

    21.45
    3.38%
    0.55
    Low: 21.4
    High: 22.1
    Market Trading Hours* (UTC) Opens on Thursday at 01:30

    Mon - Fri: 01:30 - 04:00 05:00 - 08:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.55
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026274 %
    Charges from full value of position ($-4.99)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026274%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004357 %
    Charges from full value of position ($0.83)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004357%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency HKD
    Margin 5%
    Stock exchange Hong Kong
    Commission on trade 0%

    *Information provided by Capital.com

    Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 22.2
    Open* 22
    1-Year Change* 13.11%
    Day's Range* 21.4 - 22.1
    52 wk Range 19.22-27.70
    Average Volume (10 days) 540.79K
    Average Volume (3 months) 7.61M
    Market Cap 50.58B
    P/E Ratio 7.59
    Shares Outstanding 1.63B
    Revenue 81.03B
    EPS 2.88
    Dividend (Yield %) 3.71899
    Beta 0.68
    Next Earnings Date Mar 15, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 29, 2023 21.75 -0.25 -1.14% 22.00 22.10 21.75
    Nov 28, 2023 22.20 0.20 0.91% 22.00 22.40 21.90
    Nov 27, 2023 22.10 -0.45 -2.00% 22.55 22.60 22.00
    Nov 24, 2023 22.45 1.00 4.66% 21.45 22.55 21.45
    Nov 23, 2023 21.80 0.50 2.35% 21.30 22.00 21.30
    Nov 22, 2023 21.45 0.55 2.63% 20.90 21.80 20.90
    Nov 21, 2023 21.00 0.50 2.44% 20.50 21.25 20.50
    Nov 20, 2023 20.55 0.10 0.49% 20.45 20.75 20.30
    Nov 17, 2023 20.40 0.25 1.24% 20.15 20.85 20.15
    Nov 16, 2023 20.35 -0.20 -0.97% 20.55 20.65 20.35
    Nov 15, 2023 20.60 0.30 1.48% 20.30 20.60 20.30
    Nov 14, 2023 20.25 0.15 0.75% 20.10 20.40 20.10
    Nov 13, 2023 20.30 0.15 0.74% 20.15 20.35 19.80
    Nov 10, 2023 20.15 -0.10 -0.49% 20.25 20.35 20.15
    Nov 9, 2023 20.40 -0.05 -0.24% 20.45 20.70 20.40
    Nov 8, 2023 20.65 -0.20 -0.96% 20.85 21.15 20.60
    Nov 7, 2023 20.80 -0.05 -0.24% 20.85 21.15 20.65
    Nov 6, 2023 21.15 0.30 1.44% 20.85 21.25 20.80
    Nov 3, 2023 20.70 0.30 1.47% 20.40 20.75 20.25
    Nov 2, 2023 20.40 -0.20 -0.97% 20.60 20.75 20.35

    Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 70788.2 69014.1 61673.7 64951.8 42233.8
    Revenue 70788.2 69014.1 61673.7 64951.8 42233.8
    Cost of Revenue, Total 57516.1 55792.6 51257.3 52092.6 32224.6
    Gross Profit 13272.1 13221.4 10416.4 12859.1 10009.2
    Total Operating Expense 65718 64231.2 58004.2 60899.2 38399
    Selling/General/Admin. Expenses, Total 7890.66 7903.36 6329.89 8361.46 6871.99
    Research & Development 777.95 837.424 577.059 543.369 558.362
    Depreciation / Amortization 587.366 528.648 498.554 443.573 213.317
    Interest Expense (Income) - Net Operating -450.28 -528.559 -402.433 -155.76 -530.888
    Other Operating Expenses, Total -591.342 -259.305 -259.994 -387.224 -1057.67
    Operating Income 5070.2 4782.84 3669.53 4052.58 3834.81
    Gain (Loss) on Sale of Assets
    Other, Net -26.9531 -59.7689 69.5507 75.9566 183.919
    Net Income Before Taxes 5043.24 4723.07 3739.08 4128.53 4018.73
    Net Income After Taxes 4253.37 3968.99 3091.63 3441.29 3533.72
    Minority Interest -286.848 -249.108 -176.383 -252.403 -92.7361
    Net Income Before Extra. Items 3966.52 3719.88 2915.24 3188.88 3440.98
    Net Income 3966.52 3719.88 2915.24 3188.88 3440.98
    Income Available to Common Excl. Extra. Items 3966.52 3719.88 2915.24 3188.88 3440.98
    Income Available to Common Incl. Extra. Items 3966.52 3719.88 2915.24 3188.88 3440.98
    Diluted Net Income 3966.52 3719.88 2915.24 3188.88 3440.98
    Diluted Weighted Average Shares 1625.79 1625.79 1625.79 1625.79 1625.79
    Diluted EPS Excluding Extraordinary Items 2.43975 2.28804 1.79312 1.96144 2.1165
    Dividends per Share - Common Stock Primary Issue 0.424
    Diluted Normalized EPS 2.43328 2.26582 1.79507 1.96792 2.18103
    Unusual Expense (Income) -12.4733 -42.9874 3.82206 1.13955 119.322
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 18341.8 21628.5 15982.2 17585.5 16681.9
    Revenue 18341.8 21628.5 15982.2 17585.5 16681.9
    Cost of Revenue, Total 15125.7 16693.6 13613.8 14519.9 13871.7
    Gross Profit 3216.09 4934.89 2368.49 3065.59 2810.21
    Total Operating Expense 17161.3 19275.8 15369.1 16456.2 15612.8
    Selling/General/Admin. Expenses, Total 1993.79 2569.27 2047.28 1817.13 1853.04
    Research & Development 221.184 179.39 155.068 223.067 202.439
    Interest Expense (Income) - Net Operating -129.199 -130.959 -320.469 -75.7328 -11.5529
    Unusual Expense (Income) -0.07601 -0.36393 0.19216 -0.32701 -0.54634
    Other Operating Expenses, Total -50.1374 -35.2074 -126.687 -27.8447 -302.345
    Operating Income 1180.53 2352.76 613.108 1129.3 1069.18
    Other, Net -2.82522 2.22754 -26.817 -4.5779 -0.72949
    Net Income Before Taxes 1177.7 2354.99 586.291 1124.72 1068.45
    Net Income After Taxes 952.688 1969.05 568.638 935.801 857.386
    Minority Interest -50.0405 -60.4545 -76.4824 -51.43 -73.0305
    Net Income Before Extra. Items 902.648 1908.6 492.155 884.371 784.355
    Net Income 902.648 1908.6 492.155 884.371 784.355
    Income Available to Common Excl. Extra. Items 902.648 1908.6 492.155 884.371 784.355
    Income Available to Common Incl. Extra. Items 902.648 1908.6 492.155 884.371 784.355
    Diluted Net Income 902.648 1908.6 492.155 884.371 784.355
    Diluted Weighted Average Shares 1625.79 1625.79 1625.79 1625.79 1625.79
    Diluted EPS Excluding Extraordinary Items 0.55521 1.17395 0.30272 0.54396 0.48245
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 0.55517 1.17376 0.30283 0.5438 0.48218
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 57064.3 52810.6 47396.6 45982.2 43031.3
    Cash and Short Term Investments 22978.6 21013.4 17819.1 18511.1 17656.9
    Cash 20804.7 20946 17739 16830.5 15050.1
    Cash & Equivalents 67.3176 26.1768 1639.12 1064.79
    Short Term Investments 2173.89 0 54 41.4952 1542.04
    Total Receivables, Net 20652.4 19174.8 17015.3 17216.1 15228.7
    Accounts Receivable - Trade, Net 14857.6 12816.5 12389.7 12555 10872.5
    Total Inventory 10671.6 10437.7 9764.53 9490.04 9231.74
    Prepaid Expenses 915.591 794.173 1081.67 744.1 888.793
    Other Current Assets, Total 1846.19 1390.46 1716 20.8704 25.1713
    Total Assets 74665.3 66117.8 59760.1 56893.7 51482.2
    Property/Plant/Equipment, Total - Net 6570.12 5835.88 5260.4 4726.1 3646.05
    Property/Plant/Equipment, Total - Gross 11233.9 9994.76 9083.66 8145.45 6628.1
    Accumulated Depreciation, Total -4663.78 -4158.88 -3823.25 -3419.34 -2982.05
    Goodwill, Net 829.473 829.473 825.573 825.573 825.573
    Intangibles, Net 2825.77 2592.96 2450.32 2487.3 1013.35
    Long Term Investments 6103.66 3105.27 2963.83 2161.67 2299.88
    Other Long Term Assets, Total 1271.97 943.637 863.312 710.777 666.04
    Total Current Liabilities 37395.1 32253.9 29243.2 29377 26948.8
    Accounts Payable 11200.3 11287.2 10874.8 9698.95 9313.28
    Accrued Expenses 2660.45 1361.47 1083.4 1544.84 1406.38
    Notes Payable/Short Term Debt 12928.8 11905.5 11550.3 9851.43 8561.88
    Other Current Liabilities, Total 9898.82 7453.94 5498.64 8052.37 7463.2
    Total Liabilities 42600.2 37055.6 33615.2 32708.9 29797.3
    Total Long Term Debt 2185.05 1250.51 1059.37 551.495 521.738
    Long Term Debt 1639.2 752.812 497.55 4.5 413.554
    Deferred Income Tax 394.588 331.728 286.359 266.909 249.762
    Minority Interest 1572.73 2264.48 2060.42 1804.69 1458.82
    Other Liabilities, Total 1052.69 955.032 965.831 708.803 618.187
    Total Equity 32065.1 29062.2 26144.8 24184.8 21684.9
    Common Stock 1625.79 1625.79 1625.79 1625.79 1625.79
    Additional Paid-In Capital 10105.7 9956.95 9885.01 9865.08 9865.08
    Retained Earnings (Accumulated Deficit) 20346.5 17496.9 14651.7 12694.1 10194.5
    Other Equity, Total 2.75475 -17.4764 -17.6735 -0.13896 -0.47714
    Total Liabilities & Shareholders’ Equity 74665.3 66117.8 59760.1 56893.7 51482.2
    Total Common Shares Outstanding 1625.79 1625.79 1625.79 1625.79 1625.79
    Current Port. of LT Debt/Capital Leases 706.732 245.803 236.107 229.361 204.024
    Capital Lease Obligations 545.843 497.698 561.824 546.995 108.185
    Unrealized Gain (Loss) -15.6557
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 52925 53820.2 55437.2 57064.3 52858.4
    Cash and Short Term Investments 19930.8 21088.2 20302.8 22978.6 21723.7
    Cash & Equivalents
    Short Term Investments 56.8727 1300.68 56.8727 2173.89 50.6686
    Total Receivables, Net 21167.3 21887.3 23040.9 20652.4 20005.4
    Accounts Receivable - Trade, Net 16521.8 16102.5 15951.4 14857.6 15161.5
    Total Inventory 9657.39 9162.56 8945.1 10671.6 8439.79
    Prepaid Expenses 857.654 579.163 503.399 915.591 620.051
    Other Current Assets, Total 1311.82 1102.93 2644.94 1846.19 2069.55
    Total Assets 74353.3 73607.2 73658.3 74665.3 69552.6
    Property/Plant/Equipment, Total - Net 7029.23 6770.05 6624.77 6570.12 6045.7
    Goodwill, Net 829.473 829.473 829.473 829.473 829.473
    Intangibles, Net 2885.87 2885.73 2822.48 2825.77 2562.35
    Long Term Investments 9097.68 7562.46 6655.58 6103.66 6082.15
    Other Long Term Assets, Total 1586.1 1739.37 1288.83 1271.97 1174.5
    Total Current Liabilities 32688.7 33049.3 32889 37395.1 31987
    Accounts Payable 12620.6 11949.2 11090.4 11200.3 11718.2
    Accrued Expenses 1140.69 2378.36 987.005 2660.45 976.886
    Notes Payable/Short Term Debt 11689.1 11934.9 12075.2 12928.8 11867.2
    Current Port. of LT Debt/Capital Leases 354.2 884.433 684.043 706.732 636.403
    Other Current Liabilities, Total 6884.19 5902.42 8052.3 9898.82 6788.32
    Total Liabilities 39693.3 39921.3 39690.5 42600.2 38123.8
    Total Long Term Debt 3764.19 3491.34 3716.26 2185.05 2228.35
    Long Term Debt 3133.04 2913.59 3136.58 1639.2 1751.9
    Capital Lease Obligations 631.144 577.752 579.671 545.843 476.447
    Deferred Income Tax 463.901 648.185 402.904 394.588 353.265
    Minority Interest 1715.88 1689.13 1633.11 1572.73 2450.18
    Other Liabilities, Total 1060.57 1043.41 1049.22 1052.69 1104.98
    Total Equity 34660.1 33685.9 33967.8 32065.1 31428.8
    Common Stock 1625.79 1625.79 1625.79 1625.79 1625.79
    Additional Paid-In Capital 10105.7 10105.7 10105.7 10105.7 9957
    Retained Earnings (Accumulated Deficit) 22947.7 21967.7 22255.1 20346.5 19854.4
    Other Equity, Total -19.1267 8.75182 -18.7811 2.75475 -8.34349
    Total Liabilities & Shareholders’ Equity 74353.3 73607.2 73658.3 74665.3 69552.6
    Total Common Shares Outstanding 1625.79 1625.79 1625.79 1625.79 1625.79
    Cash 19874 19787.6 20245.9 20804.7 21673
    Property/Plant/Equipment, Total - Gross 11678.3 2066.42 11233.9 1752.47
    Accumulated Depreciation, Total -4908.25 -4663.78
    Unrealized Gain (Loss) -22.0436 -15.6557
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Cash From Operating Activities 6999.08 5673.5 585.185 5022.37 5216.89
    Cash Taxes Paid -2759.33 -2873.35 -2637.89 -2998.66 -2158.12
    Changes in Working Capital 6999.08 5673.5 585.185 5022.37 5216.89
    Cash From Investing Activities -7253.19 -931.569 -1088.06 -1028.4 1109.72
    Capital Expenditures -1383.87 -1254.92 -876.503 -2399.81 -478.617
    Other Investing Cash Flow Items, Total -5869.31 323.348 -211.554 1371.42 1588.33
    Cash From Financing Activities 45.9498 -1493.98 1439.38 -2231.81 -2751.34
    Financing Cash Flow Items -8.90345 -396.831 -29.9475 -606.1 -410.892
    Total Cash Dividends Paid -1490.54 -1266.06 -1289.91 -1045.69 -870.559
    Issuance (Retirement) of Debt, Net 1545.39 168.908 2759.24 -580.025 -1469.89
    Foreign Exchange Effects -0.50326 0.28283 -4.99446 -0.14847 0.80701
    Net Change in Cash -208.665 3248.23 931.51 1762.01 3576.08
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Cash From Operating Activities -2838.88 6999.08 3299.47 1712.21 918.064
    Cash Taxes Paid -1004.83 -2759.33 -2152.58 -1459 -816.54
    Changes in Working Capital -2838.88 6999.08 3299.47 1712.21 918.064
    Cash From Investing Activities -638.056 -7253.19 -5873.83 -2630.43 -429.199
    Capital Expenditures -234.832 -1383.87 -898.324 -550.585 -274.643
    Other Investing Cash Flow Items, Total -403.224 -5869.31 -4975.51 -2079.84 -154.556
    Cash From Financing Activities 1571.44 45.9498 1291.27 1094.51 848.638
    Financing Cash Flow Items 0.42527 -8.90345 387.949 863.484 -4.18243
    Total Cash Dividends Paid -89.6695 -1490.54 -1398.89 -1140.22 -88.0997
    Issuance (Retirement) of Debt, Net 1660.68 1545.39 2302.21 1371.25 940.92
    Foreign Exchange Effects 1.79747 -0.50326 -0.8763 5.22974 -0.56164
    Net Change in Cash -1903.7 -208.665 -1283.97 181.526 1336.94
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 16.0441 35281000 2248000 2023-05-24 LOW
    LSV Asset Management Investment Advisor 6.0264 13252000 0 2022-12-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.1204 6861712 0 2023-09-30 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.3024 2864000 -4000 2023-09-30 LOW
    Goldman Sachs Asset Management, L.P. Investment Advisor 0.7405 1628323 46 2023-09-30 LOW
    China Merchants Fund Management Co. Ltd. Investment Advisor 0.5576 1226193 856000 2023-06-30 MED
    MOS Capital Investment Advisor/Hedge Fund 0.3929 864000 864000 2022-12-31 HIGH
    Goldman Sachs Asset Management International Investment Advisor 0.2492 548000 0 2023-08-31 MED
    California Public Employees' Retirement System Pension Fund 0.1965 432000 -50000 2022-06-30 LOW
    Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 0.191 420000 0 2023-09-30 LOW
    Focusbridge Investments Limited Investment Advisor 0.1592 350000 350000 2023-06-30 HIGH
    First Trust Advisors L.P. Investment Advisor 0.1355 297995 -17065 2023-08-31 MED
    Charles Schwab Investment Management, Inc. Investment Advisor 0.116 255142 -740 2023-09-30 LOW
    Dimensional Fund Advisors, Ltd. Investment Advisor 0.1137 250000 6000 2023-09-30 LOW
    AXA Investment Managers UK Ltd. Investment Advisor/Hedge Fund 0.1119 246000 0 2023-08-31 LOW
    LähiTapiola Varainhoito Oy Investment Advisor 0.0937 206000 0 2022-03-31 LOW
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.091 200000 0 2023-08-31 LOW
    State Street Global Advisors (UK) Ltd. Investment Advisor/Hedge Fund 0.0877 192764 -4 2023-09-30 LOW
    Russell Investments Limited Investment Advisor 0.0809 178000 0 2023-09-30 MED
    HAC VermögensManagement AG Investment Advisor 0.0782 172000 -86000 2023-03-31 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Guangzhou Baiyunshan Pharma Company profile

    About Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd

    Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd i is engaged in the pharmaceutical and healthcare industry. The Company's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The Company's Great South TCM includes research, development, manufacturing and sales for Chinese and western medicine, chemical raw medicine, natural drug, biological medicine and intermediates of chemical raw medicine. The Company's Great Health segment includes the research, development, manufacturing and sales of beverages, foods, health products and other products. The Company's Great Commerce segment includes wholesale, retail, import and export for western medicine, Chinese medicine and medical apparatus and instruments. The Great Medical segment is engaged in medical services, traditional Chinese medicine health preservation, modern pension and medical equipment industry.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd revenues increased 12% to RMB69.01B. Net income increased 28% to RMB3.72B. Revenues reflect Business segment increase of 8% to RMB46.89B, Health segment increase of 38% to RMB10.87B, Foreign segment increase of 7% to RMB42.8M. Net income benefited from Change in Fair value decrease from RMB8.5M (expense) to RMB196.9M (income).

    Industry: Pharmaceuticals (NEC)

    荔湾区沙面北街45号
    GUANGZHOU
    GUANGDONG 510130
    CN

    Income Statement

    • Annual
    • Quarterly

    News

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023

    People also watch

    Gold

    2,038.93 Price
    -0.110% 1D Chg, %
    Long position overnight fee -0.0191%
    Short position overnight fee 0.0109%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    XRP/USD

    0.62 Price
    -0.330% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    BTC/USD

    38,189.85 Price
    +0.460% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    US100

    16,075.70 Price
    +0.430% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading